date,title,source
Oct-19-18,Merrimack's String of Failures Continues With Lung Cancer Study Shelved After Midstage Trials,Benzinga
Oct-19-18,Merrimack Pharmaceuticals' stock plummets toward record low after cancer drug trial terminated,MarketWatch
Oct-19-18,Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility,PR Newswire
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-31-18,Merrimack Announces Timing of Third Quarter 2018 Investor Conference Call,PR Newswire
Nov-05-18,5 Drug/Biotech Stocks Set to Trump Estimates in Q3 Earnings,Zacks
Nov-06-18,Merrimack Pharmaceuticals Q3 Earnings Preview,Benzinga
